Anthony D. Elias, MD, on Triple-Negative Breast Cancer: PARP Inhibitors in the Current Treatment Landscape from parp Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Anthony D. Elias, MD, of the University of Colorado Cancer Center, reviews new NCCN recommendations for PARP inhibitor therapy in TNBC and the implications of the now-approved olaparib for gBRCA-mutant breast cancer.